id="u068ab298-d76c-5ed0-9ca6-65abc8370b3c">
This workbook is dedicated to everyone who made it their mission in life to discover and manufacture Essential Medicines and to: Professor Louis S. Hegedus
Who inspired this workbook project with a lesson learned at Colorado State University: An hour in the library will save you from two weeks of floundering around in the laboratory.
About the Companion Website
www.wiley.com/go/Harrington/routes_essential_medicine
Introduction
While teaching undergraduate Organic Chemistry at University of Colorado, I was asked if I could teach a course in organic synthesis. I have worked as synthetic organic chemist and educator for my entire career (Princeton University, Colorado State University, SUNY Binghamton, Syntex, Roche, University of Denver, University of Colorado, and Better Pharma Processes, LLC) but I realized I was not prepared to teach the course. This workbook project began with that missed opportunity.
In my first Organic Chemistry class at Canisius College more than forty years ago, I recognized the power synthetic organic chemists have to create new medicines to improve human healthcare. With great power comes great responsibility. The synthetic organic chemistry community accepted this responsibility: the result is our World Health Organization (WHO) Model List of Essential Medicines.
Routes to Essential Medicines: A Workbook for Organic Synthesis highlights the synthetic organic chemistry in the manufacturing routes of nearly three hundred medicines on the World Health Organization (WHO) Model List of Essential Medicines (20th List from March 2017). The workbook includes all the medicines on the list for which synthetic organic chemistry plays an important role in the manufacturing process.
Routes to Essential Medicines: A Workbook for Organic Synthesis is intended for use by upper‐level undergraduate students and graduate students participating in a course in organic synthesis or medicinal chemistry. Students using this workbook will become familiar with the structures and synthetic challenges associated with nearly three hundred essential medicines and gain an appreciation for the manufacture of specialty chemical starting materials. Students who use this workbook will develop a solid foundation for their academic and postacademic research: an extensive favorites list of key journal and information sites and a personal library of reagents, solvents, and conditions for many workhorse organic reactions. Classroom discussion and extended discussion time will provide valuable experience presenting route and reagent options and mechanisms.
For many students, this workbook will be a first encounter with the Essential Medicines on the WHO List. These medicines are the milestones in our progress in improving human healthcare in the last 100 years. The structural features of these medicines and the synthetic strategies used to create these medicines are the current state of the art and the foundation we will build upon to move human healthcare ahead for the next 100 years. How important are the Essential Medicines? In 2020 they are critically important. They are life‐and‐death important. I look out my office window on a world practicing social distancing to slow the spread of covid19. We wait for “the answer,” a drug to speed recovery from the infection, better yet, a drug to stop the spread of the virus. An optimal drug would be a drug with known and tolerable side effects, a drug which can be produced and distributed quickly, an inexpensive drug. This description fits many of the Essential Medicines on the WHO List so it comes as no surprise that many of the medicines in this workbook are being evaluated as an answer for covid19.
Workbook Organization
The workbook is organized by INN (International Non‐Proprietary Name) of the essential medicines in alphabetical order. The presentation for each target molecule begins with the structure of the target and the indications for the drug taken from the Model List. For example, for amiodarone:
From the List:
12. Cardiovascular Medicines
12.3 Antihypertensive Medicines
In the workbook:
Cardiovascular Medicines/Antihypertensive Medicines
In a group setting, each target presentation could begin with some discussion of indications, old and new. The breadth and depth of that discussion is tailored to match the time allotted and the talents and interests of the group. In many cases the discussion could be extended to include new analogs of an old drug.
One route is presented for each target molecule in most cases. The route usually has the shortest sequence from starting materials to target molecule, is adequately described in the literature, and is likely to be close to a manufacturing route still in use today.
At first glance at the target structure, previous knowledge and experience are used to create “back of the envelope” ideas for synthesis of the target. A text box highlights one idea from the list which was most influential in guiding the decision‐making leading to the presented route. Students should add ideas to create their own list as they work through the synthesis.
The route is presented as a retrosynthetic analysis accompanied by a brief text Discussion. Experimental details, references and mechanisms are not provided so that students will first focus on the structures and key disconnections. Students are then tasked to search for, evaluate, and present the procedure details (reagent(s), solvent(s), temperature, reaction time, workup, percent yield) which are the keys to the success of each reaction and the overall route. A discussion of mechanisms could accompany or follow the discussion of procedure details.
The simple sentence structure and limited vocabulary used in the text Discussion are intended to facilitate understanding by non‐English‐speaking readers. The Discussion includes tested online search terms (names for reactions, intermediates, and starting materials). The name used for an intermediate or starting material is the name commonly encountered in an online search. Name reactions are highlighted in bold. Some questions or tasks are (embedded) in the Discussion to draw attention to multiple options for reagent(s) for a reaction, selectivity data, or critical separation procedures.
The schemes are usually presented left‐to‐right without the use of retrosynthetic arrows. Retrosynthetic arrows are used to avoid confusion in some schemes. Only carbon‐containing reagents, intermediates, and products are shown. One structure in a scheme often has the positions relevant to the text Discussion numbered.
The discussion is often written so that each sentence describes one reaction. This allows the discussion to be read as a description of the retrosynthesis or the synthesis. To illustrate, for amiodarone:
Retrosynthesis: The phenol is iodinated in both ortho positions. The phenol is formed by demethylation of the ether. The ketone is formed by acylation of 2‐butyl‐2,3‐benzofuran with 4‐methoxybenzoyl chloride (Friedel–Crafts Acylation). 4‐Methoxybenzoyl chloride is formed from para‐anisic acid.
Synthesis:
